A number of reports regarding atypical fractures of the femur have raised questions concerning the possible correlation between long-term bisphosphonate treatment and the occurrence of insufficiency fractures in the proximal femur. However, clinically, it is often confused whether is it a fatigue fracture because of implant induced stress concentration or a bisphosphonate-related atypical fracture, especially in a patient with a subtrochanteric fracture who receive bisphosphonate therapy after open reduction and internal fixation, such as dynamic hip screw (DHS) fixation for previous ipsilateral femoral neck or intertrochanteric fracture. The authors experienced a case of a progressive femoral insufficiency fracture in a woman who had been on Fosamax (Alendronic acid with Vitamin D; Merck & Co. Inc, NJ, USA) therapy for four years after ipsilateral femoral neck fracture treated with a two hole DHS system. Despite a high suspicion of an insufficiency femoral subtrochanteric fracture by bone scan, the occult fracture progressed to a displaced femoral subtrochanteric fracture one year after. The fracture site was fixed with a 6 hole DHS plate, and six months after reoperation the patient had no symptoms and the fracture site had united without any complication.
INTRODUCTION
Although bisphosphonate, a potent inhibitor of bone resorption, is generally safe and effective, it carries the potential risk of over-suppressing bone turnover. Therefore, bisphosphonate therapy can potentially impair some of the biomechanical properties of bone. [1] A number of reports have been issued regarding insufficiency femoral fractures in patients on long-term bisphosphonate therapy, [2, 3] and recently several studies have reported suspicious relationship between atypical femoral fractures and long-term bisphosphonate medication. [2, 3] However, it is often confused clinically whether is it a fatigue fracture because of implant induced stress concentration or a bisphosphonate-related atypical fracture, especially in a patient with a subtrochanteric fracture who receive bisphosphonate therapy after open reduction and internal fixation, such as dynamic hip screw (DHS) system for previous ipsilateral femoral neck or intertrochanteric fracture.
In this report, we present a case of progressive femoral insufficiency fracture or stress fracture in a woman on long-term alendronate therapy who had had an ipsilateral femoral neck fracture treated using a DHS.
CASE REPORT
A 76-year old woman visited our out-patient clinic in which is a definite feature commonly presented at stress related fatigue fracture. The fracture was fixed by replacing the 2 hole DHS plate with a with a 6 hole plate. Alendronate was stopped after reoperation, and six months after the reoperation the patient was asymptomatic and the fracture had united without any complication (Fig. 2 ).
DISCUSSION
The above case report is limited in a specific situation [7] concluded that a longer dual-energy X-ray absorptiometry femoral scan might be helpful for detecting atypical subtrochanteric femur fractures based on the idea that the femoral scan field would depict hypertrophied femoral cortex or a transverse fracture line.
However, in our case, plain radiography and computed tomography showed no structural abnormality. Only a bone scan detected the fracture prior to cortical bone change in the proximal femur. We were not able to perform magnetic resonance imaging due to the presence of the metal implant.
In this case, the fracture initiated at just distal to the plate of DHS system. Biomechanically, weight stress concentrates on the most distal margin of a plate after internal fixation. We consider that in our case, over-suppression of bone turnover interfered with normal bone healing after microfracture induced by stress concentration. To our knowledge, this is the first study to report on the development of an insufficiency or stress-induced fatigue femoral fracture and to describe the effectiveness of bone scan as early diagnostic modality.
In retrospect, the bisphosphonate should have been stopped after we detected the insufficiency femoral fracture.
Puah and Tan [8] reported that a bisphosphonate-associated atypical fracture of the femur spontaneous heal after drug suspension and re-appeared after resumption. Unfortunately, we did not recognize the possible affect of bisphosphonate at the time.
Most studies that have addressed insufficiency femoral fractures have recommended that physicians should check plain femoral radiographs when patients with a history of long-term bisphosphonate medication complain of persistent thigh pain. [3] It is also recommended for cases with suspicious fatigue fracture. We would add that a bone scan be added for early detection purposes when no structural bone abnormality is detected by plain radiography. In these situation, preventive internal fixation before development of displaced femoral fracture could be a beneficial.
